Familial Dilated Cardiomyopathy: Understanding the Genetic Basis and Management
Author Information
Author(s): Matthew Taylor, Elisa Carniel, Luisa Mestroni
Primary Institution: University of Colorado Cardiovascular Institute and Adult Medical Genetics Program
Hypothesis
Familial dilated cardiomyopathy (FDC) is primarily caused by genetic mutations affecting cardiac myocyte proteins.
Conclusion
Familial dilated cardiomyopathy is a significant genetic condition that can be managed through early identification and treatment strategies.
Supporting Evidence
- Familial dilated cardiomyopathy accounts for 20-48% of dilated cardiomyopathy cases.
- Genetic mutations in cytoskeletal and sarcomeric proteins are principal causes of familial dilated cardiomyopathy.
- Early identification through family history and genetic testing can lead to better management of the disease.
Takeaway
Some heart problems run in families, and doctors can help find out who might get sick early so they can start taking care of their hearts.
Methodology
The study reviews existing literature on familial dilated cardiomyopathy, its genetic basis, and management strategies.
Potential Biases
Potential bias in the selection of families for genetic studies may affect the generalizability of findings.
Limitations
The genetic epidemiology of mutations in familial dilated cardiomyopathy remains poorly defined due to the focus on selected families.
Participant Demographics
The study discusses familial dilated cardiomyopathy in adults, with a focus on genetic factors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website